The South Dakota Office of the South Dakota Attorney General has joined with 49 other states, the District of Columbia, Puerto Rico, and the federal government to settle allegations of fraud against Mallinckrodt ARD, LLC (formerly known as Questcor Pharmaceuticals, Inc.), a U.S. subsidiary of the Irish pharmaceutical company Mallinckrodt PLC (collectively Mallinckrodt). Mallinckrodt’s U.S. headquarters is located in Bedminster, New Jersey, from which they sell and market pharmaceutical products nationwide.
The total value of the settlement is $233,707,865.18, plus interest, to be paid over a seven-year period. The total settlement amount recovered by South Dakota is $89,172.26, of which $48,636.57 will be retained by the federal government for the federal Medicaid share. The remaining $40,535.69 will go to the state general fund to offset alleged Medicaid damages in this case.